CONTRAFECT Corp
CFRXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001478069
CONTRAFECT Corp was delisted in 2023; its insiders filed their last Form 4 on Feb 16, 2023; 40 institutions reported holding it in 13F filings for Q4 2022, worth $1.08M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 40
- Q4 2022, −5 vs. previous quarter
- 13F value
- $1.08M
- Reported value at the end of Q4 2022
- Superinvestors holding
- 0
- At the end of Q4 2022
Superinvestors holding CFRX, Q4 2022
No superinvestor reported holding CFRX at the end of Q4 2022.
Latest insider trades
Open-market purchases and sales by CONTRAFECT Corp insiders from Form 4, newest first.
No open-market purchases or sales by CONTRAFECT Corp insiders are on file.
Top 10 13F holders, Q4 2022
The largest institutional positions in CONTRAFECT Corp at the end of Q4 2022; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 4,095,150 | $393.1K | 0.01% | +4,095,150 | New |
| Acadian Asset Management LLC | 1,588,806 | $151.0K | 0.00% | 00.0% | Unchanged |
| Artal Group S.A. | 1,500,000 | $144.0K | 0.01% | 00.0% | Unchanged |
| Fosun International Ltd | 745,385 | $74.5K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 519,432 | $49.9K | 0.00% | +1,606+0.3% | Added |
| Renaissance Technologies LLC | 477,900 | $46.0K | 0.00% | +351,200+277.2% | Added |
| Vanguard Group Inc | 423,968 | $40.7K | 0.00% | −205,531−32.6% | Reduced |
| Geode Capital Management, LLC | 329,729 | $31.0K | 0.00% | −756−0.2% | Reduced |
| Virtu Financial LLC | 271,242 | $26.0K | 0.00% | +89,069+48.9% | Added |
| Two Sigma Investments, LP | 187,551 | $18.0K | 0.00% | −45,100−19.4% | Reduced |